fludarabine has been researched along with Adenocarcinoma, Basal Cell in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guillen, KP; Harrison, RG; Kurkjian, C; Restuccia, A | 1 |
| Barkholt, L; Ericzon, BG; Mattsson, J; Omazic, B; Potácová, Z; Remberger, M; Ringdén, O; Söderdahl, G; Wersäll, P | 1 |
| Bossow, S; Cattaneo, R; Grossardt, C; Leber, MF; Rieber, EP; Sawall, S; Temme, A; Ungerechts, G; von Kalle, C | 1 |
| Albiin, N; Barkholt, L; Hentschke, P; Martola, J; Mattsson, J; Pisa, P; Remberger, M; Ringdén, O; Söderberg, M; Thörne, A; Uzunel, M; Wernerson, A; Wersäll, P | 1 |
| Hiruma, K; Maeda, Y; Matsumoto, G; Omuro, Y; Sakamaki, H; Sasaki, T; Takahashi, T; Tanaka, Y; Tsuruta, K | 1 |
| Caracciolo, F; Fazzi, R; Galimberti, S; Petrini, M | 1 |
| Bertetto, O; Busca, A; de Fabritiis, P; Falda, M; Locatelli, F; Novarino, A; Picardi, A; Zeuli, M | 1 |
| Aprahamian, M; Deharvengt, S; Hajri, A; Rejiba, S; Wack, S | 1 |
| Clark, G; Hersh, M; Hutton, JJ; Kuhn, J; Phillips, J; Von Hoff, DD | 1 |
| Hapke, DM; Mitchell, BS; Stegmann, AP | 1 |
10 other study(ies) available for fludarabine and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Annexin V-Directed Enzyme Prodrug Therapy Plus Docetaxel for the Targeted Treatment of Pancreatic Cancer.
Topics: Adenine; Adenocarcinoma; Annexin A5; Antineoplastic Combined Chemotherapy Protocols; Carbon-Sulfur Lyases; Cell Death; Cell Line, Tumor; Cytosine Deaminase; Docetaxel; Dose-Response Relationship, Drug; Enzymes; Flucytosine; Fluorouracil; Humans; Methanol; Molecular Targeted Therapy; Organoselenium Compounds; Pancreatic Neoplasms; Prodrugs; Purine-Nucleoside Phosphorylase; Recombinant Fusion Proteins; Selenomethionine; Taxoids; Tubulin Modulators; Vidarabine | 2015 |
Long-Term Follow-Up of Allogeneic Hematopoietic Stem Cell Transplantation for Solid Cancer.
Topics: Adenocarcinoma; Adult; Aged; Bile Duct Neoplasms; Breast Neoplasms; Colonic Neoplasms; Cyclophosphamide; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Kidney Neoplasms; Male; Middle Aged; Myeloablative Agonists; Neoplasm Metastasis; Pancreatic Neoplasms; Prostatic Neoplasms; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2016 |
Armed and targeted measles virus for chemovirotherapy of pancreatic cancer.
Topics: Adenocarcinoma; Animals; Antigens, Neoplasm; Antineoplastic Agents; Cell Line, Tumor; Chlorocebus aethiops; Combined Modality Therapy; Female; GPI-Linked Proteins; Humans; Male; Measles virus; Mice; Mice, SCID; Neoplasm Proteins; Oncolytic Virotherapy; Pancreatic Neoplasms; Prodrugs; Purine-Nucleoside Phosphorylase; Vero Cells; Vidarabine; Xenograft Model Antitumor Assays | 2011 |
Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma.
Topics: Adenocarcinoma; Aged; Breast Neoplasms; Cholangiocarcinoma; Colonic Neoplasms; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Middle Aged; Retrospective Studies; Stem Cell Transplantation; Survival Analysis; Time Factors; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2003 |
Regression of an unresectable pancreatic tumor following nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.
Topics: Adenocarcinoma; Cyclophosphamide; Female; Graft vs Host Disease; Histocompatibility Testing; Humans; Living Donors; Middle Aged; Pancreatic Neoplasms; Siblings; Stem Cell Transplantation; Time Factors; Tomography, X-Ray Computed; Transplantation Conditioning; Treatment Outcome; Vidarabine | 2003 |
Early reappearance of primary solid cancer in patients treated with purine analogs.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Colic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Purines; Remission Induction; Treatment Outcome; Vidarabine | 2003 |
Nonmyeloablative allogeneic blood stem cell transplantation in patients with metastatic solid tumors.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Renal Cell; Colonic Neoplasms; Feasibility Studies; Female; Graft Survival; Graft vs Host Disease; Graft vs Tumor Effect; Humans; Immunosuppressive Agents; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Rectal Neoplasms; Sarcoma; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2006 |
Efficient electrogene therapy for pancreatic adenocarcinoma treatment using the bacterial purine nucleoside phosphorylase suicide gene with fludarabine.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Electrochemotherapy; Electroporation; Gene Transfer Techniques; Genes, Bacterial; Genes, Transgenic, Suicide; Genetic Therapy; Humans; Neoplasms, Experimental; Pancreatic Neoplasms; Prodrugs; Purine-Nucleoside Phosphorylase; Rats; Rats, Inbred Lew; RNA, Messenger; Vidarabine; Xenograft Model Antitumor Assays | 2007 |
Phase I clinical investigation of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate (NSC 312887), a new purine antimetabolite.
Topics: Adenocarcinoma; Arabinonucleotides; Drug Evaluation; Female; Humans; Kinetics; Lung Neoplasms; Male; Neoplasms; Vidarabine; Vidarabine Phosphate | 1984 |
Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biotransformation; Breast Neoplasms; Carcinoma, Small Cell; Cladribine; Colonic Neoplasms; Cytarabine; Deoxycytidine Kinase; DNA, Complementary; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Genetic Vectors; Humans; Lung Neoplasms; Moloney murine leukemia virus; Phosphorylation; Recombinant Fusion Proteins; Tumor Cells, Cultured; Vidarabine | 1996 |